HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$5.16
Day range
$5.05 - $5.20
Year range
$4.71 - $12.43
Market cap
732.26M USD
Avg Volume
1.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 50.30M | 46.19% |
Operating expense | 43.57M | -13.58% |
Net income | -10.75M | 58.98% |
Net profit margin | -21.37 | 71.94% |
Earnings per share | -0.07 | 61.11% |
EBITDA | -1.72M | 94.03% |
Effective tax rate | -7.38% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 319.37M | -11.50% |
Total assets | 516.63M | 14.36% |
Total liabilities | 157.16M | 156.15% |
Total equity | 359.48M | — |
Shares outstanding | 143.02M | — |
Price to book | 2.06 | — |
Return on assets | -3.09% | — |
Return on capital | -3.56% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.75M | 58.98% |
Cash from operations | -18.60M | 41.28% |
Cash from investing | 49.23M | 98.04% |
Cash from financing | -15.05M | -1,018.30% |
Net change in cash | 15.58M | 401.37% |
Free cash flow | -4.02M | 82.08% |
About
Founded
2012
Headquarters
Website
Employees
300